Hao Bao

2.0k total citations
35 papers, 1.2k citations indexed

About

Hao Bao is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hao Bao has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hao Bao's work include Renal Diseases and Glomerulopathies (15 papers), Chronic Kidney Disease and Diabetes (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Hao Bao is often cited by papers focused on Renal Diseases and Glomerulopathies (15 papers), Chronic Kidney Disease and Diabetes (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Hao Bao collaborates with scholars based in China, United States and United Kingdom. Hao Bao's co-authors include Zhihong Liu, Caihong Zeng, Weixin Hu, Kai Deng, Y. Hu, Weibo Le, LI Leishi, Haitao Zhang, Honglang Xie and Weisong Qin and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Hao Bao

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Bao China 17 612 362 270 164 161 35 1.2k
Atsuko Nakagawa Japan 16 177 0.3× 186 0.5× 60 0.2× 54 0.3× 299 1.9× 43 1.0k
Fan Lian China 18 48 0.1× 298 0.8× 234 0.9× 69 0.4× 139 0.9× 39 999
Victor Moyo United States 25 112 0.2× 384 1.1× 73 0.3× 270 1.6× 311 1.9× 69 2.1k
R.I. Carr United States 14 197 0.3× 432 1.2× 692 2.6× 34 0.2× 718 4.5× 27 1.9k
Huihua Ding China 20 110 0.2× 892 2.5× 393 1.5× 26 0.2× 484 3.0× 64 1.6k
Byoung Kwon Kim South Korea 18 153 0.3× 264 0.7× 69 0.3× 28 0.2× 234 1.5× 40 956
Viola T. Kung United States 13 120 0.2× 837 2.3× 114 0.4× 79 0.5× 126 0.8× 22 1.5k
Ah‐Kau Ng United States 17 114 0.2× 203 0.6× 232 0.9× 44 0.3× 407 2.5× 27 1.1k
Diana Rubel Australia 21 128 0.2× 273 0.8× 26 0.1× 74 0.5× 125 0.8× 43 1.4k
Temy Mo Yin Mok Hong Kong 2 182 0.3× 1.0k 2.9× 32 0.1× 126 0.8× 447 2.8× 2 1.3k

Countries citing papers authored by Hao Bao

Since Specialization
Citations

This map shows the geographic impact of Hao Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Bao more than expected).

Fields of papers citing papers by Hao Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Bao. The network helps show where Hao Bao may publish in the future.

Co-authorship network of co-authors of Hao Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Bao. A scholar is included among the top collaborators of Hao Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Bao. Hao Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corte, Tamera J., Deepthi Nair, Hao Bao, et al.. (2025). Long-term Safety and Efficacy Data With Inhaled Pirfenidone (AP01) in the Atlas Open-label Extension Study Up to 240 Weeks. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2906–A2906.
2.
Yue, Xuejing, et al.. (2025). NAD + Enhanced on Hearing Recovery in Sudden Sensorineural Hearing Loss: Randomized Controlled Trial. The Laryngoscope. 136(3). 1204–1214.
3.
Chen, Jinglei, Aiping Duan, Feng Xu, et al.. (2025). Engineered RGD‐Treg‐Exos Targeted Delivery of miR‐218‐5p to Activate Mitophagy and Attenuate Podocyte Injury in Diabetic Kidney Disease. Advanced Science. 12(37). e12034–e12034. 1 indexed citations
4.
Wang, Jianli, Hao Bao, Dandan Liu, et al.. (2025). Exploring the location patterns and clinical characteristics of isolated simple renal cysts: insights from a multicenter retrospective study. World Journal of Urology. 43(1). 105–105.
5.
Bao, Hao, et al.. (2025). Extremely Early Ambulation after Bariatric and Metabolic Surgery: A Randomized Controlled Trial. Obesity Surgery. 36(1). 46–53. 1 indexed citations
6.
Li, Yi, et al.. (2024). Screening of potential drugs for the treatment of diabetic kidney disease using single-cell transcriptome sequencing and connectivity map data. Biochemical and Biophysical Research Communications. 725. 150263–150263. 3 indexed citations
7.
Ma, Rui, et al.. (2024). Cotton Verticillium wilt monitoring based on UAV multispectral-visible multi-source feature fusion. Computers and Electronics in Agriculture. 217. 108628–108628. 21 indexed citations
8.
Zhu, Tangsong, Yang Hu, Yong Wang, et al.. (2024). rs-TAC PDC, a peptide drug-conjugate, for targeted delivery of tacrolimus and sericin alleviates podocyte injury in diabetic nephropathy. Nano Today. 57. 102385–102385. 1 indexed citations
9.
10.
11.
Qin, Weisong, Xiaodong Xu, Xiaodong Zhu, et al.. (2020). Upregulated LRRC55 promotes BK channel activation and aggravates cell injury in podocytes. The Journal of Experimental Medicine. 218(2). 16 indexed citations
12.
Qin, Weisong, Jin‐Song Shi, Qin Hou, et al.. (2019). C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis. JCI Insight. 4(7). 28 indexed citations
13.
Qin, Weisong, et al.. (2019). Upregulated long noncoding RNA LOC105375913 induces tubulointerstitial fibrosis in focal segmental glomerulosclerosis. Scientific Reports. 9(1). 716–716. 31 indexed citations
14.
Qu, Xiaofeng, Kun Xu, Chao Zhao, et al.. (2017). Genotoxicity and acute and subchronic toxicity studies of a bioactive polyoxometalate in Wistar rats. BMC Pharmacology and Toxicology. 18(1). 26–26. 9 indexed citations
15.
Song, Dandan, Xiaofeng Qu, Yushen Liu, et al.. (2017). A Rapid Detection Method of Brucella with Quantum Dots and Magnetic Beads Conjugated with Different Polyclonal Antibodies. Nanoscale Research Letters. 12(1). 179–179. 31 indexed citations
16.
Pang, Bo, Chao Zhao, Li Li, et al.. (2017). Development of a low-cost paper-based ELISA method for rapid Escherichia coli O157:H7 detection. Analytical Biochemistry. 542. 58–62. 180 indexed citations
17.
Chen, Yinghua, Hao Bao, Zhengzhao Liu, et al.. (2017). Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA–Associated GN. Clinical Journal of the American Society of Nephrology. 12(3). 417–425. 26 indexed citations
18.
Bao, Hao, Hao Chen, Xiaodong Zhu, et al.. (2013). MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy. Kidney International. 85(3). 624–635. 51 indexed citations
19.
Bao, Hao, Yan Ge, Shougang Zhuang, et al.. (2012). Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury. Kidney International. 81(7). 662–673. 66 indexed citations
20.
Bao, Hao, Zhihong Liu, Honglang Xie, et al.. (2008). Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy. Journal of the American Society of Nephrology. 19(10). 2001–2010. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsuko Nakagawa Breakdown of academic impact, for papers by Fan Lian Breakdown of academic impact, for papers by Victor Moyo Breakdown of academic impact, for papers by R.I. Carr Breakdown of academic impact, for papers by Huihua Ding Breakdown of academic impact, for papers by Byoung Kwon Kim Breakdown of academic impact, for papers by Viola T. Kung Breakdown of academic impact, for papers by Ah‐Kau Ng Breakdown of academic impact, for papers by Diana Rubel Breakdown of academic impact, for papers by Temy Mo Yin Mok
Rankless by CCL
2026